15h
Schrödinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities
Schrödinger, Inc. (Nasdaq: SDGR) provided an update on its progress across the business in 2025 and announced its strategic ...
VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback